Early research (Phase 1)Study completedNCT03814291
What this trial is testing
A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration
Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 31